Category: CannabisNewsWire Release

420 with CNW — Trial Suggests Marijuana Could Replace Opioids in Pain Management

As more states have opted to end cannabis prohibition and launch legal cannabis markets, there has been a growing body of literature indicating that the controversial plant can be effective against a variety of medical issues. Several studies have found that marijuana can be used to treat chronic pain, and plenty of people are already using the controversial plant as an alternative to pharmaceutical pain medications.

Now researchers currently working on a clinical trial to see whether cannabis can be used as an alternative to opioids in pain management have revealed that the pilot phase had “very promising” results. Run by Labat Africa, an investment holding company that trades on both the Frankfurt and JSE exchanges, the Pharma Ethics Observational Study will involve some 1,000 individuals who have been using opioids to manage chronic pain for at least three months.

In a notice to shareholders, Labat Africa said the opioid painkillers that were previously used by the participants included codeine, morphine and pethidine. Lead researcher Dr. Shiksa Gallow says the trials have been groundbreaking in giving much-needed insight between patient outcomes and marijuana genetics. Furthermore, the trials have provided enough evidence to show that cannabis can be used as an alternative to opioids when it comes to chronic pain management.

Gallow states that 98% of the study participants felt some sort of chronic pain relief after using cannabis. The researchers were even able to wean the patients off their opioid-based treatments, fixing an issue that plagues most patients that suffer from chronic pain conditions: opioid dependency. Gallow notes that participants under 55 years of age preferred to smoke the marijuana while those over 55 preferred the oil.

Unsurprisingly, the patients who smoked felt more immediate relief while those who used the oil had to wait for some time for the substance to take effect. Gallows states that once the researchers achieve the required sample size and collect all the relevant data, they will publish their findings. In the meantime, the research team has been able to extend the study for another year to allow them to recruit more participants.

The team is using cannabis strains, such as Exodus and Tallyman, that tend to work better against chronic pain conditions. According to Labat Africa, the team is planning to introduce the 9 Pound Hammer strain as it has high levels of THC, CBG and terpenes, such as myrcene and caryophyllene. Labat sources its cannabis strains from its Sweetwaters Aquaponics facility in the Eastern Cape.

It would be interesting to see how those premium cannabis strains would perform when grown in the micro gardens engineered by Advanced Container Technologies Inc. (OTC: ACTX) to maximize plant performance.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — American Medical Association Approves Measure on Expungement of Cannabis Records

Millions of Americans across the country with cannabis-related offenses on their records may soon have the offenses expunged after the largest professional association of physicians in the United States passed a resolution in favor of expunging marijuana-related offenses.

Last week, the American Medical Association (AMA) announced that it had passed a measure that would require states that have either decriminalized or legalized cannabis to expunge marijuana-related arrests and convictions that are now considered legal. The association made this announcement at its annual House Delegates meeting in Chicago, stating that it had already formally adopted this change in policy.

A statement from the AMA stated that the policy change was meant to bring fairness and equity to cannabis reform. At least 18 states have legalized recreational cannabis while 37 states have launched medical cannabis markets, the association noted. However, despite this, many people living in these states still have marijuana-related offenses related to activities that are now legal on their records. And as every American knows, having a criminal record in the U.S. has a major impact on your life, making it nigh impossible to get employment and housing, and even receive custody of your children, among other things.

AMA trustee Dr. Scott Ferguson noted that such criminal records keep many from accessing housing, education, employment, and loans. It also keeps young people from pursuing careers such as medicine, he added. He concluded that it is extremely unfair to penalize individuals and cripple them for life because of actions that have now been decriminalized or legalized.

The organization asked that the entire expungement process be automated to shorten what is a typically “lengthy and expensive” process. Automation would allow people to clear their records of cannabis-related offenses without having to go through tons of bureaucracy or pay a variety of fees.

On top of expunging records, the AMA’s new policy calls for a blanket ban on probation parole, or court-ordered supervision that involves marijuana offenses. The AMA explained that cannabis prohibition laws have never been enforced equally, with Black communities taking the brunt of cannabis arrests and convictions despite Whites showing similar cannabis use rates.

The organization mentioned data that shows Black people are 3.6 times more likely to be arrested for consuming cannabis even though research shows that Black and White people consume cannabis at the same rates.

However, the organization has stated that although it is behind expungement, it does not support further legalization. AMA cited possible health ramifications, increased traffic deaths, ER visits and marijuana-related hospitalizations as reasons for its opposition to legalization.

Concerns about marijuana notwithstanding, the American Medical Association is a great addition to the voices calling for cannabis policy changes at the federal level. The entire marijuana industry, including American Cannabis Partners, would be pleased if more professional bodies added their voices to the chorus calling for reform.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — New Congressional Measure Will Enable Cannabis Companies to List on Stock Exchanges

A pair of congressmen has introduced a bipartisan bill that seeks to allow cannabis companies to be listed on national stock exchanges. The bill would also grant the industry access to crucial financial services like banking, solving an issue that has plagued the industry since its inception.

Rep. Guy Reschenthaler and Rep. Troy Carter are the cosponsors of the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act. Filed last week, the legislation seeks to allow cannabis and ancillary businesses to access financial services such as checking accounts, cashless payments and loans, something federal law prohibits by threatening action against financial institutions that transact with these businesses.

This has forced many cannabis businesses to operate on a cash-only basis, increasing the risk of burglaries and putting customers as well as staff in danger. Furthermore, it limits the industry’s access to capital and hinders its growth.

On top of that, the CLIMB Act tackles an issue that hasn’t been raised often in the past: allowing cannabis firms to list their stock on national stock exchanges. More specifically, the bill would ensure that major stock exchanges such as the New York Stock Exchange (NYSE) and Nasdaq could list and trade the stock of registered cannabis businesses or service providers without any federal reprisal.

The CLIMB Act would be a major boon for the industry if it is passed, legitimizing the young but lucrative industry in the eyes of Wall Street and granting cannabis businesses access to much-needed banking services. It would essentially provide protections to any individual, business or agency that “provides business assistance” to a registered cannabis business. Theoretically, the federal Small Business Administration (SBA) would now be able to service state-legal cannabis businesses without fear of reprisal from the Justice Department.

According to Carter, the CLIMB Act is a great chance to bring equity and equal opportunity to the nascent cannabis industry. In a press release, he said that lack of access to capital had proven to be the most significant barrier to entry and success in the cannabis industry. The bipartisan CLIMB Act would bring some symmetry into the cannabis ecosystem and allow communities that had been disproportionately harmed by the drug war to move into the cannabis industry and benefit, he said.

As it stands, Reschenthaler said, marijuana companies in America cannot access traditional financing and lending services, making it difficult to compete with global competitors. The CLIMB Act would eliminate these barriers to entry and give America’s cannabis industry the financial tools it needs to succeed.

When U.S.-founded cannabis companies are allowed to register on domestic stock exchanges in the same way that entities with roots abroad such as Flora Growth Corp. (NASDAQ: FLGC)  can, the competition in the industry will go up several notches due to the increased flow of capital into different companies.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — House Panel Asks Military to Reconsider Cannabis Penalties for Soldiers

Federal law prohibits American servicemembers from consuming cannabis. A 2018 notice declares that although dozens of states have legalized cannabis for medical or recreational purposes, federal law restricts military members from using cannabis, CBD (cannabidiol), any cannabinoid derivatives and THC-infused products. The notice also states that the ingestion of hemp and hemp-seed derivatives was prohibited because they could contain trace amounts of THC.

This is despite the fact that studies have shown cannabis can be efficient in alleviating conditions such as, depression, chronic pain, insomnia and post-traumatic stress disorder (PTSD), which are common among military veterans.

A key House panel is now requesting the military to reconsider cannabis penalties for soldiers. The House Armed Service Committee recently approved two amendments to the National Defense Authorization Act (NDAA) that are associated with cannabis-related issues in the military. The first amendment by Rep. Anthony Brown would compel the Military Justice Review panel to develop new recommendations to specify suitable penalties for marijuana-related offenses.

This would include a comparison between the “sentencing standards” for marijuana-related offenses and similar offenses, such as misuse of alcohol. The panel would also need to account for the burden current cannabis sentencing standards place on the military justice system. The panel would have 180 days to issue a report with cannabis sentencing recommendations to the House and Armed Services Committee after the measure is enacted.

Speaking at a press release, Brown said that the military justice system needs to adjust and evolve with the times as states increasingly adopt cannabis reform. He states that while his amendment won’t change current federal law, it will require that the armed forces review its cannabis policies and provide recommendations for possible reform.

The second amendment, introduced by Rep. Seth Moulton, would require that the Department of Defense (DOD) sponsor a study into marijuana’s efficacy against certain conditions compared to opioids. The DOD prohibited all active and reserve military members from consuming hemp products back in 2019 and reiterated through notices in 2020 that CBD was also prohibited.

As per Moulton’s amendment, the secretary of defense would be required to lead a study on the efficacy of medical cannabis as an opioid alternative for Armed Forces veterans. The study would involve veterans diagnosed with a traumatic brain injury, PTSD or any condition that causes severe pain. They should have been prescribed pharmaceutical medications to address their conditions in the past.

The secretary of defense would also have to conduct regular assessments of the study subjects and issue reports to congressional defense committees one year and three years after the study. These reports would cover any benefits and risks associated with using medical cannabis as an opioid alternative and provide any pertinent recommendations.

It is crucial that the military revisits its marijuana policies. it is no longer uncommon to find people using the products from duly licensed companies such as Cannabis Strategic Ventures (OTC: NUGS) for medical or recreational reasons.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Signs LOI Outlining Minority Stake Acquisition of Cannabis Cultivation Property

Sugarmade (OTC: SGMD), an emerging leader in the vertically integrated cannabis sector, has taken steps toward a 40% acquisition of the business and associated property known as RMI Ventures (d/b/a Jerusalem Grade Farm). SGMD signed a letter of intent (“LOI”) agreeing to complete a definitive acquisition agreement that would make Sugarmade a minority owner of RMI Ventures with 40% control of RMI Ventures equity; SGMD anticipates pursuing the acquisition of additional equity in RMI Ventures next year. According to the announcement, Sugarmade intends to leverage the turnkey operation to fulfill its recently announced collaborative cannabis cultivation contract with Cannabis Global Inc. for 25,000 pounds of “Fresh Frozen” cannabis. Sugarmade representatives also noted that the new acquisition would enable the company to seek more buyers and build its sales channel to support the eventual activation of its large production site. The LOI with RMI Ventures includes associated property,  cannabis-related licenses and the business operation. “This acquisition will allow us to be more efficient on every level,” said Sugarmade CEO Jimmy Chan in the press release. “It gives us much more optionality in scaling our vertically integrated model while avoiding unnecessary costs and wasteful spending as we prepare to hit the gas pedal when market conditions are more advantageous. The RMI business is an excellent property, and we look forward to updating current and prospective shareholders as we move toward a definitive agreement and an expanded equity position.” 

To view the full press release, visit https://cnw.fm/Ve5Kq

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s portfolio includes CarryOutsupplies.com, SugarRush(TM), NUG Avenue, Lemon Glow and Budcars. For more information about the company, please visit www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Flora Growth Corp. (NASDAQ: FLGC) Anticipates Continued Growth for Cannabis Operations Under New Colombian Administration

  • Flora Growth is a cannabis cultivator and distributor with a base of operations in Colombia’s fertile growing climate, capable of feeding the company’s expanding international supply chain
  • Colombia has undergone a number of regulatory changes in recent years as it emerges from the shadows of years-long drug wars and embraces a growing global acceptance of cannabis products
  • The South American country voted in a new presidential administration in June, and Flora Growth is applauding the president-elect’s continued openness to international cannabis trade
  • Flora Growth announced significant revenue growth during its year-end financial reporting in May, and the company stated it expects another 288 to 400 percent increase in revenues during the current year

Following nationwide elections that marked a historic change in Colombia’s presidency as well as its people’s social policy aspirations, emerging cannabis brand builder Flora Growth (NASDAQ: FLGC) is expressing optimism for its market opportunities, which are based on a growing cannabis cultivation operation in the South American country. 

Longtime legislator Gustavo Petro, a sitting senator and previously Mayor of Bogota, was declared Colombia’s chief executive-elect June 19 after his remaining opponent in a runoff election conceded that Petro had won the majority of the vote in an orderly transfer of authority (https://cnw.fm/Nz0Xx).

Flora Growth enjoyed explosive energy in building an international supply chain for its cannabis products under the progressive drug policy changes instituted by outgoing President Ivan Duque’s administration, and the company anticipates Petro’s approach to the market’s opportunities will further open doors for its operations. 

“We would like to congratulate President-Elect Gustavo Petro on his victory and we look forward to working with the new government to continue Colombia’s progressive momentum in the global cannabis industry,” Flora Growth Chairman and CEO Luis Merchan stated in a recent news release (https://cnw.fm/P1Ww6). 

“We are encouraged by President-Elect Petro’s stance on seeing Colombia become a leader in the legal cannabis industry and we are hopeful for progressive legislation that will allow Colombia to create a safe environment for cannabis consumption domestically — potentially leading to a recreational market in the country,” Merchan added, while observing that Colombia’s environmental and labor conditions are ideal for building successful international commerce.

Petro signaled his support of the industry last year when he stated, “The possibility of legal exportation of marijuana for recreational and medicinal purposes through licenses from the national government has friends with political power in Colombia. If Colombia does not get its act together, we’re going to lose that business” (https://cnw.fm/HKd3z).

Flora Growth operates a 100-hectare (about 247-acre) cultivation facility known as Cosechemos in the heart of Colombia’s green grower-friendly climate. From its cultivation, extraction and isolation operations at the city of Bucaramanga, much of its product goes to its GMP-certified processing facility for beauty, phytotherapeutic and nutraceutical products in the nation’s capital, Bogotá. 

The company’s license applications with Colombia’s food and drug regulatory body have included more than 20 cannabinoid-infused food and beverage products, such as juices, sparkling seltzers, gummies, chocolates, ghee butter, and healthy snack foods, that prioritize natural ingredients and value-chain sustainability (https://cnw.fm/3nCoq).

“While approximately 90% of Flora’s forecasted revenue is expected to be derived outside of Colombia, we see Colombia as particularly well suited both for production of high-quality, cost-advantaged cannabis and the manufacturing of cannabinoid-derived medical formulations that can be sold domestically and internationally,” Flora’s Chief Commercial Officer Jason Warnock added in the company news release.

Year-end financial results announced in May reported annual revenue of about $9 million — a “significantly higher” amount than the company reported a year earlier before Colombia’s change in its drug product laws went into effect and Flora launched its IPO on the Nasdaq Capital Market. And the company stated at the time that it expects revenues to grow another 288 to 400 percent during the current year (https://cnw.fm/4q3Bp).

For more information, visit the company’s website at www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Congressional Leaders Seek to Give Indian Tribes Cannabis Protections

Several congressional leaders are looking to include language that would protect Native American tribes from being penalized by the federal government for legalizing cannabis within their territories in a variety of funding bills.

In 2014, the federal government stated that tribes were allowed to grow and sell cannabis as long as they followed the same federal guidelines set for states that had legalized cannabis. The lawmakers now want it codified into law that the federal government cannot persecute Indian tribes that legalize cannabis within their territories.

More specifically, the new cannabis provision would forbid federal funds appropriated to agencies within the Justice, Interior Department, Office of Justice Services and Bureau of Indian Affairs from being used to enforce cannabis prohibition in Native American territories where marijuana is legal. The provision states that federal funds not be used in the enforcement of federal laws that criminalize the cultivation, distribution, possession and use of cannabis in Native American country.

The provision was attached to the base of the Department of the Interior’s fiscal year 2023 appropriations legislation and needs no further amendments. However, the cannabis protection provision states that there are two exceptions: first, federal funds can be used to interfere with cannabis activities in tribal territories that are located in states without legal markets, and second Native American tribes must make sure that their tribal marijuana laws prevent access by minors, keep cannabis from being used in organized criminal activity or the trafficking of other illicit drugs, and ensure there is no cannabis on federal public lands.

In the past, provisions that had been attached to appropriations bills for Commerce, Justice, Science, and Related Agencies (CJS) that advanced past the House banned the use of federal funds in enforcing cannabis prohibition on tribal territories, but they did not have any nuance regarding different state laws nor did they offer any policy guidelines. Furthermore, none of these measures were codified into law even after advancing past the House.

Speaking at a press conference, Rep. Dave Joyce stated that it is unequivocally wrong to enforce federal cannabis laws on tribal land, especially in cases where the tribe and home state have both legalized marijuana. Joyce is a Congressional Cannabis Caucus cochair and a ranking member on the Appropriations Subcommittee on Interior, Environment, and Related Agencies.

He said misguided efforts to enforce federal cannabis policies on tribal land have left Native American tribes unsure if the federal government will continue enforcing federal cannabis policies on Native American reservations.

These tribes were sovereign nations, he noted, adding that they had the right to pass and enforce their own legislation.

Granting these protections removes a lot of concerns that people have about the risk of being penalized by the federal government for an action that is legal within the jurisdiction where they live. As these clarifications are codified, companies such as Advanced Container Technologies Inc. (OTC: ACTX) could see their sales of cultivation equipment jump.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Vehicle Insurance Data Suggests Medical Cannabis Legalization Reduces Drunk Driving

A new study has revealed that contrary to what many prohibitionists feared, medical cannabis legalization in the country has not led to an uptick in rates of intoxicated driving. In fact, the research has found that states with medical marijuana programs have seen a reduction in drunk-driving rates, adding to the growing body of research showing that there is a link between cannabis reform and a reduced risk of drunk driving.

Published in the latest issue of the journal “Health Economics,” the study analyzed auto insurance premium data from 2014 to 2019. Researchers discovered that premiums in states with legal medical cannabis programs reduced by $22 per year after cannabis legislation passed. The researchers believe that this drop in auto insurance premiums may be due to decreased rates of drunk driving as people switch from alcohol to cannabis.

Although these results don’t seem to be significant at face value, they reveal a possible link between medical cannabis reform and increased road safety. Consequently, this leads to cost savings for drivers in terms of insurance premiums and medical expenses related to car accidents. In total, the study authors wrote, medical cannabis reform has decreased auto insurance premiums by a whopping $1.5 billion in states with medical marijuana programs.

Furthermore, it would result in further savings of $900 if the states that still don’t allow medical cannabis were to legalize it, resulting in a combined $2.4 billion in auto insurance savings across the country.  The study authors wrote that their research showed evidence of a “positive social impact” on auto safety due to statewide medical cannabis reform.

Medical marijuana laws also resulted in annual cost savings of about $820 million due to reduced health expenditure; the laws have the potential to add an extra $350 million in savings if other states legalize cannabis.

Unlike previous studies that looked at the correlation between cannabis laws and traffic fatalities, this study focused on auto insurance trends. Since only a minimal percentage of car accidents result in fatalities, the researchers say focusing on fatalities didn’t paint a clear and concise picture.

But since auto-insurance companies are responsible for covering 67% of all automobile-related property and medical damage, studying insurance premium data in relation to medical cannabis laws would give the researchers a better picture of how cannabis reform has affected auto safety.

The research indicated that people are substituting alcohol for cannabis, especially in regions that experienced high rates of drunk driving before medical cannabis became legal. Licensed companies such as American Cannabis Partners may be pleasantly surprised to discover that they are indirectly contributing to improved road safety each time buyers opt for their products instead of alcoholic beverages.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Focused on International Strategy to Reach ‘Larger Consumer Base’

Flora Growth Corp. (NASDAQ: FLGC) CEO Luis Merchan is quoted in a recent article saying, “International growth is a key objective of our company’s strategy.” Earlier this year, the company completed the acquisition of 100% equity interests of Just Brands LLC and High Roller Private Label LLC, owners of the JustCBD brand, in a move by Flora Growth to explore global expansion opportunities and increase its customer database. The article reads: “By mid-May 2022, Flora Growth had already announced the expansion of its operational footprint in Europe and the United Kingdom to further its international growth strategy… In what marks a noteworthy milestone for Flora Growth and its expansion plan, the company announced that JustCBD would launch its Novel Foods registered CBD products on Amazon.co.uk… ‘The launch on Amazon UK allows Flora to reach a larger consumer base in search of quality CBD products. We are excited to continue expanding our operations in Europe and to deliver top-quality cannabis-related products to customers aiming to improve their health and wellness,’ said Merchan.”

To view the full article, visit https://cnw.fm/9D1Ro

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands delivering the most compelling customer experiences in the world, one community at a time. As the operator of one of the most extensive outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands and life sciences divisions. Visit www.FloraGrowth.com or follow @floragrowthcorp on social media for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) to Stand Distinct, Push Brand

Lexaria Bioscience Corp. (NASDAQ: LEXX) acknowledges consumers’ shift away from smoking cigarettes to nicotine alternatives, which has resulted in the growth of the nicotine pouch and nicotine replacement therapy (“NRT”) markets. Through its patented DehydraTECH technology, Lexaria looks to tap into the multibillion-dollar nicotine alternatives industry and stamp its position. “In a move that sought to prove DehydraTECH’s superiority, Lexaria conducted an oral nicotine absorption study in 2021. The research showed that Lexaria’s DehydraTECH-nicotine delivered via an oral pouch product dispensed enough nicotine levels in blood plasma in four minutes, as concentration-matched controls did in 45 minutes. In addition, peak levels of DehydraTECH-nicotine proved to be approximately ten times higher than the peak level of the controls,” a recent article reads. “With key industry players such as Altria Group, British American Tobacco Industries, Philip Morris International, and GlaxoSmithKline PLC embracing a transition to a smoke-free future, Lexaria isn’t being left behind. Instead, it recognizes the existing opportunity and is capitalizing on its DehydraTECH technology to set itself apart from its peers and aggressively push its brand in the market.”

To view the full article, visit https://cnw.fm/d2oJn

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.